gamma-aminobutyric acid has been researched along with Local Neoplasm Recurrence in 4 studies
gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In patients with brain tumors, the choice of antiepileptic medication is guided by tolerability and pharmacokinetic interactions." | 2.79 | Levetiracetam and pregabalin for antiepileptic monotherapy in patients with primary brain tumors. A phase II randomized study. ( Jeckelmann, S; Novy, J; Rossetti, AO; Roth, P; Stupp, R; Weller, M, 2014) |
| " Our data demonstrate that the timing and dosing of antiandrogens are critical to maximizing the antitumor effects of combination therapy." | 1.43 | Androgen receptor antagonists compromise T cell response against prostate cancer leading to early tumor relapse. ( Fu, YX; Guo, Y; Liang, Y; Pu, Y; Xu, M; Yang, K; Yang, X, 2016) |
| "Gabapentin, which has been suggested as an adjuvant analgesic for neuropathic pain introduced orally, rapidly and significantly alleviated his pain and we could subsequently dispense with ketamine and mexiletine." | 1.34 | [Gabapentin mitigates neuropathic pain in cancer patients--a case report]. ( Okada, M; Shinjo, T, 2007) |
| "His neuropathic pain was not sufficiently responsive to the combination therapy of opioids, non-steroidal antiinflammatory drugs (NSAIDs), continuous infusion of subcutaneous ketamine and oral mexiletine." | 1.34 | [Gabapentin mitigates neuropathic pain in cancer patients--a case report]. ( Okada, M; Shinjo, T, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rossetti, AO | 1 |
| Jeckelmann, S | 1 |
| Novy, J | 1 |
| Roth, P | 1 |
| Weller, M | 1 |
| Stupp, R | 1 |
| Pu, Y | 1 |
| Xu, M | 1 |
| Liang, Y | 1 |
| Yang, K | 1 |
| Guo, Y | 1 |
| Yang, X | 1 |
| Fu, YX | 1 |
| Touchette, D | 1 |
| Gessler, EM | 1 |
| Okada, M | 1 |
| Shinjo, T | 1 |
1 trial available for gamma-aminobutyric acid and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Levetiracetam and pregabalin for antiepileptic monotherapy in patients with primary brain tumors. A phase II randomized study.
Topics: Anticonvulsants; Brain Neoplasms; Epilepsy; Female; Follow-Up Studies; gamma-Aminobutyric Acid; Huma | 2014 |
3 other studies available for gamma-aminobutyric acid and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Androgen receptor antagonists compromise T cell response against prostate cancer leading to early tumor relapse.
Topics: Androgen Receptor Antagonists; Animals; Cell Line, Tumor; gamma-Aminobutyric Acid; Immunity; Immunot | 2016 |
Painful traumatic neuroma of the tongue treated with serial alcohol injections.
Topics: Aged; Amines; Analgesics; Anesthetics, Local; Central Nervous System Depressants; Cyclohexanecarboxy | 2011 |
[Gabapentin mitigates neuropathic pain in cancer patients--a case report].
Topics: Adenocarcinoma; Amines; Analgesics; Bone Neoplasms; Cyclohexanecarboxylic Acids; Gabapentin; gamma-A | 2007 |